Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.818 SEK | +5.14% | +18.90% | -33.50% |
05-03 | Nanexa AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-16 | Nanexa AB Announces Approval of Clinical Trial Application for NEX-22 Study Delayed | CI |
- Stock Market
- Equities
- NANEXA Stock
- News Nanexa AB
- MarketScreener Strategies